Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Michael Mulholland?

Michael S. Mulholland

Chief Executive Officer

PainReform Ltd

Direct Phone: (610) ***-****direct phone

Email: m***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

PainReform Ltd

Company Description

Established in 2007, PainReform is a venture capital backed, specialty pharmaceutical company with headquarters in Herzeliya. PainReform primarily focuses on developing reformulation of established pain therapeutics PainReform applies it propriety formulation ... more.

Find other employees at this company (3)

Background Information

Employment History

Senior Vice President

U.S. Pharmaceutical


Contributor

PR Newswire


Senior Vice President, General Manager, US Pharmaceuticals

Cephalon , Inc.


Global Vice President, Neuroscience Marketing and Head of Sales and Marketing

Wyeth


Web References(5 Total References)


PainReform - Management Team

www.painreform.com [cached]

Michael S. Mulholland
Chief Executive Officer Michael Mulholland brings over 20 years of experience in pharmaceutical marketing, sales, life cycle management and product and business development. He has successfully commercialized products and built businesses in both the US and Europe and has held significant leadership roles as an executive and general manager. Mr. Mulholland was Senior Vice President and General Manager of Cephalon's US pharmaceutical business which is comprised of over 800 employees, spans CNS, pain and oncology and generates annual revenues in excess of $2 billion. In this role he spearheaded numerous product acquisitions, launches and partnerships which lead to top line growth of $1 billion over just four years. Prior to joining Cephalon, Mr. Mulholland held various leadership roles at Wyeth including Global Vice President, Neuroscience Marketing and Head of Sales and Marketing in their UK affiliate which was Wyeth's largest ex-US operation. In the UK he was responsible for all commercial activities for a product portfolio spanning CNS, gastroenterology and Women's Health Care and generating $800 million in annual sales. Earlier in his career Mr. Mulholland held roles of increasing responsibility in both sales and marketing at Pfizer, Bristol -Myers Squibb and Pharmacia where he had a consistent record of building high performance teams and delivering strong operating results. Mr. Mulholland holds an MBA from the Johnson Graduate School of Management at Cornell University and sits on the Board of Advisors to the Fordham School of Business. Michael S. Mulholland


PEMSS 2007 Speakers

www.pharmexecsummit.com [cached]

Mike Mulholland, Vice President, US Pharmaceutical Operations, Cephalon


www.prnewswire.com

Michael S. Mulholland, Senior Vice President, U.S. Pharmaceutical Operations at Cephalon, Inc.


inVentiv Health - About Us - Newsroom - Press Releases

www.inventivit.com [cached]

"inVentiv has an impressive track record and they've demonstrated a great willingness to work with us to help us achieve our goals," said Michael S. Mulholland, Senior Vice President, U.S. Pharmaceutical Operations at Cephalon, Inc.


Windhover Information Inc.

www.windhoverinfo.com [cached]

CNS: Michael Mulholland, VP Neuroscience, Global Strategic Marketing, Wyeth Pharmaceuticals


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory